Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.3 % |
3 Month Return | -0.06 % |
1 Year Return | -19.4 % |
Market Stats | |
Previous Close | ₹80.21 |
Open | ₹82.99 |
Volume | 1,084.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹189.75Cr |
P/E Ratio | -41.29 |
PEG Ratio | 21.18 |
Market Cap | ₹189.75 Cr |
P/B Ratio | 2.24 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 5.74 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹189.75 Cr | 330.09% | 0.62 | -₹25 Cr | ₹42 Cr | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Bafna Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Wins Export Performance Award - 09 Sep, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 62.4%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 142.5%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 11.70% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 88.30% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 88.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 11.7% | 0.00 | |
Others | 0% | 0.00 |
Bafna Pharmaceuticals Ltd in the last 5 years
Lowest (-114.08x)
December 17, 2020
Today (-41.29x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (-2.36x)
March 2, 2020
Bafna Pharmaceuticals Ltd’s net profit jumped 53.91% since last year same period to ₹0.59Cr in the Q2 2019-2020. On a quarterly growth basis, Bafna Pharmaceuticals Ltd has generated 72.3% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Bafna Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Bafna Pharmaceuticals Ltd share price today stands at ₹80.52, Open. ₹82.99 ; Previous Close. ₹80.21 ; High. ₹84.22 ; Low. ₹80 ; 52 Week High. ₹113 ; 52 Week Low: ₹73.25.
Bafna Pharmaceuticals Ltd is listed on NSE
Bafna Pharmaceuticals Ltd is listed on BSE
PE Ratio of Bafna Pharmaceuticals Ltd is -41.29
PE ratio = Bafna Pharmaceuticals Ltd Market price per share / Bafna Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Bafna Pharmaceuticals Ltd(BAFNAPH) is 1,084.00.
Today’s market capitalisation of Bafna Pharmaceuticals Ltd(BAFNAPH) is ₹189.75Cr.
Bafna Pharmaceuticals Ltd(BAFNAPH | Price |
---|---|
52 Week High | ₹113 |
52 Week Low | ₹73.25 |
Bafna Pharmaceuticals Ltd(BAFNAPH) share price is ₹80.52. It is down -28.74% from its 52 Week High price of ₹113
Bafna Pharmaceuticals Ltd(BAFNAPH) share price is ₹80.52. It is up 9.92% from its 52 Week Low price of ₹73.25
Bafna Pharmaceuticals Ltd(BAFNAPH | Returns |
---|---|
1 Day Returns | 0.31% |
1 Month Returns | -1.3% |
3 Month Returns | -0.06% |
1 Year Returns | -19.4% |